{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T14:55:56Z","timestamp":1791298556327,"version":"4.1.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T00:00:00Z","timestamp":1791244800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T00:00:00Z","timestamp":1791244800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Abdom Radiol"],"DOI":"10.1007\/s00261-026-05814-5","type":"journal-article","created":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T14:48:09Z","timestamp":1791298089000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["DCE-MRI histogram analysis for predicting survival in patients with epithelial ovarian carcinoma"],"prefix":"10.1007","author":[{"given":"Juanru","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruihong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Limei","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiale","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinliang","family":"Niu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Li","family":"song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,6]]},"reference":[{"issue":"4","key":"5814_CR1","doi-asserted-by":"publisher","first-page":"e70090","DOI":"10.3322\/caac.70090","volume":"76","author":"H Sung","year":"2026","unstructured":"Sung H, Filho AM, Laversanne M, et al. Global cancer statistics 2024: GLOBOCAN estimates of incidence and mortality worldwide for 34 cancers in 186 countries. CA Cancer J Clin, 2026, 76 (4):e70090. https:\/\/doi.org\/10.3322\/caac.70090.","journal-title":"CA Cancer J Clin"},{"issue":"5","key":"5814_CR2","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1038\/s41571-024-00881-3","volume":"21","author":"PM Webb","year":"2024","unstructured":"Webb PM, Jordan SJ. Global epidemiology of epithelial ovarian cancer. Nat Rev Clin Oncol, 2024, 21 (5):389\u2013400. https:\/\/doi.org\/10.1038\/s41571-024-00881-3.","journal-title":"Nat Rev Clin Oncol"},{"issue":"30","key":"5814_CR3","doi-asserted-by":"publisher","first-page":"3468","DOI":"10.1200\/jco.20.01924","volume":"38","author":"WP Tew","year":"2020","unstructured":"Tew WP, Lacchetti C, Ellis A, et al. PARP Inhibitors in the Management of Ovarian Cancer: ASCO Guideline. J Clin Oncol, 2020, 38 (30):3468\u20133493. https:\/\/doi.org\/10.1200\/jco.20.01924.","journal-title":"J Clin Oncol"},{"issue":"10","key":"5814_CR4","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1016\/j.annonc.2023.07.011","volume":"34","author":"A Gonz\u00e1lez-Mart\u00edn","year":"2023","unstructured":"Gonz\u00e1lez-Mart\u00edn A, Harter P, Leary A, et al. Newly diagnosed and relapsed epithelial ovarian cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up. Ann Oncol, 2023, 34 (10):833\u2013848. https:\/\/doi.org\/10.1016\/j.annonc.2023.07.011.","journal-title":"Ann Oncol"},{"issue":"10177","key":"5814_CR5","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1016\/s0140-6736(18)32552-2","volume":"393","author":"S Lheureux","year":"2019","unstructured":"Lheureux S, Gourley C, Vergote I, et al. Epithelial ovarian cancer. Lancet, 2019, 393 (10177):1240\u20131253. https:\/\/doi.org\/10.1016\/s0140-6736(18)32552-2.","journal-title":"Lancet"},{"key":"5814_CR6","doi-asserted-by":"publisher","unstructured":"Winter WE, 3rd, Maxwell GL, Tian C, et al. Prognostic factors for stage III epithelial ovarian cancer: a Gynecologic Oncology Group Study. J Clin Oncol, 2007, 25 (24):3621\u20137. https:\/\/doi.org\/10.1200\/jco.2006.10.2517.","DOI":"10.1200\/jco.2006.10.2517"},{"issue":"5","key":"5814_CR7","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1093\/annonc\/mdz062","volume":"30","author":"N Colombo","year":"2019","unstructured":"Colombo N, Sessa C, du Bois A et al (2019) ESMO-ESGO consensus conference recommendations on ovarian cancer: pathology and molecular biology, early and advanced stages, borderline tumours and recurrent disease\u2020. Ann Oncol 30(5):672\u2013705. https:\/\/doi.org\/10.1093\/annonc\/mdz062","journal-title":"Ann Oncol"},{"issue":"3","key":"5814_CR8","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.annonc.2023.11.015","volume":"35","author":"JA Ledermann","year":"2024","unstructured":"Ledermann JA, Matias-Guiu X, Amant F et al (2024) ESGO-ESMO-ESP consensus conference recommendations on ovarian cancer: pathology and molecular biology and early, advanced and recurrent disease. Ann Oncol 35(3):248\u2013266. https:\/\/doi.org\/10.1016\/j.annonc.2023.11.015","journal-title":"Ann Oncol"},{"issue":"1","key":"5814_CR9","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1148\/radiol.204371","volume":"303","author":"EA Sadowski","year":"2022","unstructured":"Sadowski EA, Thomassin-Naggara I, Rockall A et al (2022) O-RADS MRI Risk Stratification System: Guide for Assessing Adnexal Lesions from the ACR O-RADS Committee. Radiology 303(1):35\u201347. https:\/\/doi.org\/10.1148\/radiol.204371","journal-title":"Radiology"},{"issue":"6","key":"5814_CR10","doi-asserted-by":"publisher","first-page":"2248","DOI":"10.1007\/s00330-016-4600-3","volume":"27","author":"R Forstner","year":"2017","unstructured":"Forstner R, Thomassin-Naggara I, Cunha TM, et al. ESUR recommendations for MR imaging of the sonographically indeterminate adnexal mass: an update. Eur Radiol, 2017, 27 (6):2248\u20132257. https:\/\/doi.org\/10.1007\/s00330-016-4600-3.","journal-title":"Eur Radiol"},{"issue":"12","key":"5814_CR11","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1007\/s11547-020-01220-z","volume":"125","author":"G Petralia","year":"2020","unstructured":"Petralia G, Summers PE, Agostini A, et al. Dynamic contrast-enhanced MRI in oncology: how we do it. Radiol Med, 2020, 125 (12):1288\u20131300. https:\/\/doi.org\/10.1007\/s11547-020-01220-z.","journal-title":"Radiol Med"},{"issue":"1","key":"5814_CR12","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1002\/jmri.21377","volume":"28","author":"I Thomassin-Naggara","year":"2008","unstructured":"Thomassin-Naggara I, Dara\u00ef E, Cuenod CA, et al. Dynamic contrast-enhanced magnetic resonance imaging: a useful tool for characterizing ovarian epithelial tumors. J Magn Reson Imaging, 2008, 28 (1):111\u201320. https:\/\/doi.org\/10.1002\/jmri.21377.","journal-title":"J Magn Reson Imaging"},{"issue":"1","key":"5814_CR13","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.mric.2023.09.001","volume":"32","author":"X Li","year":"2024","unstructured":"Li X, Huang W, Holmes JH (2024) Dynamic Contrast-Enhanced (DCE) MRI. Magn Reson Imaging Clin N Am 32(1):47\u201361. https:\/\/doi.org\/10.1016\/j.mric.2023.09.001","journal-title":"Magn Reson Imaging Clin N Am"},{"key":"5814_CR14","doi-asserted-by":"publisher","first-page":"110925","DOI":"10.1016\/j.ejrad.2023.110925","volume":"165","author":"A Lindgren","year":"2023","unstructured":"Lindgren A, Anttila M, Arponen O, et al. Dynamic contrast-enhanced MRI to characterize angiogenesis in primary epithelial ovarian cancer: An exploratory study. Eur J Radiol, 2023, 165:110925. https:\/\/doi.org\/10.1016\/j.ejrad.2023.110925.","journal-title":"Eur J Radiol"},{"issue":"8","key":"5814_CR15","doi-asserted-by":"publisher","first-page":"e0221340","DOI":"10.1371\/journal.pone.0221340","volume":"14","author":"A Lindgren","year":"2019","unstructured":"Lindgren A, Anttila M, Rautiainen S, et al. Dynamic contrast-enhanced perfusion parameters in ovarian cancer: Good accuracy in identifying high HIF-1\u03b1 expression. PLoS One, 2019, 14 (8):e0221340. https:\/\/doi.org\/10.1371\/journal.pone.0221340.","journal-title":"PLoS One"},{"key":"5814_CR16","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.ejrad.2019.03.023","volume":"115","author":"A Lindgren","year":"2019","unstructured":"Lindgren A, Anttila M, Arponen O, et al. Prognostic value of preoperative dynamic contrast-enhanced magnetic resonance imaging in epithelial ovarian cancer. Eur J Radiol, 2019, 115:66\u201373. https:\/\/doi.org\/10.1016\/j.ejrad.2019.03.023.","journal-title":"Eur J Radiol"},{"issue":"12","key":"5814_CR17","doi-asserted-by":"publisher","first-page":"2205","DOI":"10.1038\/bjc.2014.512","volume":"111","author":"N Just","year":"2014","unstructured":"Just N. Improving tumour heterogeneity MRI assessment with histograms. Br J Cancer, 2014, 111 (12):2205\u201313. https:\/\/doi.org\/10.1038\/bjc.2014.512.","journal-title":"Br J Cancer"},{"issue":"4","key":"5814_CR18","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/j.ejca.2011.11.036","volume":"48","author":"P Lambin","year":"2012","unstructured":"Lambin P, Rios-Velazquez E, Leijenaar R, et al. Radiomics: extracting more information from medical images using advanced feature analysis. Eur J Cancer, 2012, 48 (4):441\u20136. https:\/\/doi.org\/10.1016\/j.ejca.2011.11.036.","journal-title":"Eur J Cancer"},{"issue":"4","key":"5814_CR19","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.ejca.2011.12.025","volume":"48","author":"MC Asselin","year":"2012","unstructured":"Asselin MC, O\u2019Connor JP, Boellaard R, et al. Quantifying heterogeneity in human tumours using MRI and PET. Eur J Cancer, 2012, 48 (4):447\u201355. https:\/\/doi.org\/10.1016\/j.ejca.2011.12.025.","journal-title":"J Cancer"},{"issue":"1","key":"5814_CR20","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1007\/s00261-021-03288-1","volume":"47","author":"KE Kim","year":"2022","unstructured":"Kim KE, Kim CK. Magnetic resonance imaging-based texture analysis for the prediction of postoperative clinical outcome in uterine cervical cancer. Abdom Radiol (NY), 2022, 47 (1):352\u2013361. https:\/\/doi.org\/10.1007\/s00261-021-03288-1.","journal-title":"Abdom Radiol (NY)"},{"key":"5814_CR21","doi-asserted-by":"publisher","first-page":"109745","DOI":"10.1016\/j.ejrad.2021.109745","volume":"140","author":"X Ma","year":"2021","unstructured":"Ma X, Shen M, He Y, et al. The role of volumetric ADC histogram analysis in preoperatively evaluating the tumour subtype and grade of endometrial cancer. Eur J Radiol, 2021, 140:109745. https:\/\/doi.org\/10.1016\/j.ejrad.2021.109745.","journal-title":"Eur J Radiol"},{"issue":"3","key":"5814_CR22","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1007\/s00261-025-05146-w","volume":"51","author":"KX Wang","year":"2026","unstructured":"Wang KX, Yu J, Xu Q, et al. Application of histogram analysis based on DCE-MRI in predicting metachronous liver metastasis and metastasis-free survival in rectal cancer. Abdom Radiol (NY), 2026, 51 (3):1347\u20131359. https:\/\/doi.org\/10.1007\/s00261-025-05146-w.","journal-title":"Abdom Radiol (NY)"},{"issue":"4","key":"5814_CR23","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1016\/j.rcl.2023.02.006","volume":"61","author":"C Panico","year":"2023","unstructured":"Panico C, Avesani G, Zormpas-Petridis K, et al. Radiomics and Radiogenomics of Ovarian Cancer: Implications for Treatment Monitoring and Clinical Management. Radiol Clin North Am, 2023, 61 (4):749\u2013760. https:\/\/doi.org\/10.1016\/j.rcl.2023.02.006.","journal-title":"Radiol Clin North Am"},{"issue":"9","key":"5814_CR24","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.1177\/0284185119898654","volume":"61","author":"HM Li","year":"2020","unstructured":"Li HM, Tang W, Feng F, et al. Whole solid tumor volume histogram parameters for predicting the recurrence in patients with epithelial ovarian carcinoma: a feasibility study on quantitative DCE-MRI. Acta Radiol, 2020, 61 (9):1266\u20131276. https:\/\/doi.org\/10.1177\/0284185119898654.","journal-title":"Acta Radiol"},{"issue":"3","key":"5814_CR25","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.ygyno.2014.04.013","volume":"133","author":"DG Mutch","year":"2014","unstructured":"Mutch DG, Prat J (2014) 2014 FIGO staging for ovarian, fallopian tube and peritoneal cancer. Gynecol Oncol 133(3):401\u20134. https:\/\/doi.org\/10.1016\/j.ygyno.2014.04.013","journal-title":"Gynecol Oncol"},{"issue":"2","key":"5814_CR26","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1158\/1078-0432.Ccr-14-0990","volume":"21","author":"JP O\u2019Connor","year":"2015","unstructured":"O\u2019Connor JP, Rose CJ, Waterton JC, et al. Imaging intratumor heterogeneity: role in therapy response, resistance, and clinical outcome. Clin Cancer Res, 2015, 21 (2):249\u201357. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-14-0990.","journal-title":"Clin Cancer Res"},{"issue":"4","key":"5814_CR27","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1002\/jmri.10176","volume":"16","author":"AR Padhani","year":"2002","unstructured":"Padhani AR. Dynamic contrast-enhanced MRI in clinical oncology: current status and future directions. J Magn Reson Imaging, 2002, 16 (4):407\u201322. https:\/\/doi.org\/10.1002\/jmri.10176.","journal-title":"J Magn Reson Imaging"},{"key":"5814_CR28","doi-asserted-by":"publisher","unstructured":"Tofts PS, Brix G, Buckley DL et al (1999) Estimating kinetic parameters from dynamic contrast-enhanced T(1)-weighted MRI of a diffusable tracer: standardized quantities and symbols. J Magn Reson Imaging 10(3):223\u201332. https:\/\/doi.org\/10.1002\/(sici)1522-2586(199909)10:3%3C223::aid-jmri2%3E3.0.co;2-s","DOI":"10.1002\/(sici)1522-2586(199909)10:3%3C223::aid-jmri2%3E3.0.co;2-s"},{"issue":"1","key":"5814_CR29","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1158\/2159-8290.Cd-21-1059","volume":"12","author":"D Hanahan","year":"2022","unstructured":"Hanahan D. Hallmarks of Cancer: New Dimensions. Cancer Discov, 2022, 12 (1):31\u201346. https:\/\/doi.org\/10.1158\/2159-8290.Cd-21-1059.","journal-title":"Cancer Discov"},{"issue":"10","key":"5814_CR30","doi-asserted-by":"publisher","first-page":"2464","DOI":"10.3390\/cancers14102464","volume":"14","author":"P Derlatka","year":"2022","unstructured":"Derlatka P, Grabowska-Derlatka L, Halaburda-Rola M, et al. The Value of Magnetic Resonance Diffusion-Weighted Imaging and Dynamic Contrast Enhancement in the Diagnosis and Prognosis of Treatment Response in Patients with Epithelial Serous Ovarian Cancer. Cancers (Basel), 2022, 14 (10):2464. https:\/\/doi.org\/10.3390\/cancers14102464.","journal-title":"Cancers (Basel)"},{"key":"5814_CR31","doi-asserted-by":"publisher","first-page":"102008","DOI":"10.1016\/j.canep.2021.102008","volume":"75","author":"SA Said","year":"2021","unstructured":"Said SA, Bretveld RW, Koffijberg H, et al. Clinicopathologic predictors of early relapse in advanced epithelial ovarian cancer: development of prediction models using nationwide data. Cancer Epidemiol, 2021, 75:102008. https:\/\/doi.org\/10.1016\/j.canep.2021.102008.","journal-title":"Cancer Epidemiol"},{"issue":"6","key":"5814_CR32","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1002\/cncr.24149","volume":"115","author":"A du Bois","year":"2009","unstructured":"du Bois A, Reuss A, Pujade-Lauraine E, et al. Role of surgical outcome as prognostic factor in advanced epithelial ovarian cancer: a combined exploratory analysis of 3 prospectively randomized phase 3 multicenter trials: by the Arbeitsgemeinschaft Gynaekologische Onkologie Studiengruppe Ovarialkarzinom (AGO-OVAR) and the Groupe d\u2019Investigateurs Nationaux Pour les Etudes des Cancers de l\u2019Ovaire (GINECO). Cancer, 2009, 115 (6):1234\u201344. https:\/\/doi.org\/10.1002\/cncr.24149.","journal-title":"Cancer"},{"issue":"9","key":"5814_CR33","doi-asserted-by":"publisher","first-page":"Cd015048","DOI":"10.1002\/14651858.CD015048.pub2","volume":"9","author":"A Bryant","year":"2022","unstructured":"Bryant A, Hiu S, Kunonga PT, et al. Impact of residual disease as a prognostic factor for survival in women with advanced epithelial ovarian cancer after primary surgery. Cochrane Database Syst Rev, 2022, 9 (9):Cd015048. https:\/\/doi.org\/10.1002\/14651858.CD015048.pub2.","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"5814_CR34","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1214\/08-AOAS169","volume":"2","author":"H Ishwaran","year":"2008","unstructured":"Ishwaran H, Kogalur UB, Blackstone EH, et al. Random survival forests. Ann Appl Stat., 2008, 2 (3):841\u2013860. https:\/\/doi.org\/10.1214\/08-AOAS169.","journal-title":"Ann Appl Stat."},{"key":"5814_CR35","unstructured":"Ehrlinger J, ggRandomForests: Exploring random forest survival. arXiv preprint arXiv:1612.08974IF: NA NA NA, 2016. ."}],"container-title":["Abdominal Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00261-026-05814-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00261-026-05814-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00261-026-05814-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T14:48:11Z","timestamp":1791298091000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00261-026-05814-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,6]]},"references-count":35,"alternative-id":["5814"],"URL":"https:\/\/doi.org\/10.1007\/s00261-026-05814-5","relation":{},"ISSN":["2366-0058"],"issn-type":[{"value":"2366-0058","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,6]]},"assertion":[{"value":"13 July 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}